RAPIDPoint 400/405/500 Systems and RAPIDLab 1240/1245/1260/1265 Systems (blood gas analysers). An in vitro diagnostic medical device (IVD). 의 리콜

Department of Health, Therapeutic Goods Administration에 따르면, 해당 리콜 는 Australia 에서 Siemens Healthcare Pty Ltd 에 의해 제조된 제품과 관련되어 있습니다.

이것은 무엇인가요?

의료기기에 문제가 생겼을 경우 제조사가 이를 바로잡거나 시장에서 회수하는 조치를 말한다. 회수(Recall)는 의료기기에 결함이 있거나, 건강에 위협이 되거나, 또는 결함도 있고 건강에도 위협이 될 경우에 발생한다.

데이터에 대해 더 자세히 알아보기 여기
  • 사례 유형
    Recall
  • 사례 ID
    RC-2016-RN-01098-1
  • 사례 위험등급
    Class II
  • 사례 시작날짜
    2016-08-22
  • 사례 국가
  • 사례 출처
    DHTGA
  • 사례 출처 URL
  • 비고 / 경고
    Australian data is current through July 2018. All of the data comes from the Australian Therapeutic Goods Administration, except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Australia.
  • 데이터 추가 비고
  • 원인
    Siemens has identified that when all of a particular set of steps occur there is a potential for the first and/or last name of one patient to be printed with patient id and result data from a different patient, even when those fields have been turned off for the system. the steps are: 1. analyser is configured with patient demographics (last name, first name) disabled and rapid sample identification transaction (host query) turned on. 2. patient id barcode is scanned at analysis screen prior to sample being analysed and is not the barcode for the patient sample being tested. 3. patient id and last name are not confirmed and/or corrected at the analysis screen. 4. the sample is analysed and correct patient id is entered at demographics screen.An incorrect patient name on the blood gas printout has the potential to lead to patient mismanagement.The patient id and patient test result data are correct on the analyser screen and the lis.
  • 조치
    Siemens is advising users to not configure the Siemens Blood Gas Analyser with the patient demographics (last name, first name) turned Off and the Rapid Sample Identification Option turned On. In addition, if sample IDs are scanned at the analysis screen, users should confirm that the patient ID is correct on the screen prior to analysing the sample. And, if the patient ID is not correct, correct it at the analysis screen.

Device

  • 모델명 / 제조번호(시리얼번호)
    RAPIDPoint 400/405/500 Systems and RAPIDLab 1240/1245/1260/1265 Systems (blood gas analysers). An in vitro diagnostic medical device (IVD).Various models affectedARTG Number: 175890
  • Manufacturer

Manufacturer